Browse > Article
http://dx.doi.org/10.3345/kjp.2018.61.2.49

Treatment-failure tularemia in children  

Karli, Arzu (Division of Pediatric Infectious Diseases, Ondokuz Mayis University Faculty of Medicine)
Sensoy, Gulnar (Division of Pediatric Infectious Diseases, Ondokuz Mayis University Faculty of Medicine)
Paksu, Sule (Department of Pediatrics, Ondokuz Mayis University Faculty of Medicine)
Korkmaz, Muhammet Furkan (Department of Pediatrics, Ondokuz Mayis University Faculty of Medicine)
Ertugrul, Omer (Department of Pediatrics, Ondokuz Mayis University Faculty of Medicine)
Karli, Rifat (Departments of Otorhinolaryngology, Ondokuz Mayis University Faculty of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.61, no.2, 2018 , pp. 49-52 More about this Journal
Abstract
Purpose: Tularemia is an infection caused by Francisella tularensis. Its diagnosis and treatment may be difficult in many cases. The aim of this study was to evaluate treatment modalities for pediatric tularemia patients who do not respond to medical treatment. Methods: A single-center, retrospective study was performed. A total of 19 children with oropharyngeal tularemia were included. Results: Before diagnosis, the duration of symptoms in patients was $32.15{\pm}17.8days$. The most common lymph node localization was the cervical chain. All patients received medical treatment (e.g., streptomycin, gentamicin, ciprofloxacin, and doxycycline). Patients who had been given streptomycin, gentamicin, or doxycycline as initial therapy for 10-14 days showed no response to treatment, and recovery was only achieved after administration of oral ciprofloxacin. Response to treatment was delayed in 5 patients who had been given ciprofloxacin as initial therapy. Surgical incision and drainage were performed in 9 patients (47.5%) who were unresponsive to medical treatment and were experiencing abcess formation and suppuration. Five patients (26.3%) underwent total mass excision, and 2 patients (10.5%) underwent fine-needle aspiration to reach a conclusive differential diagnosis and inform treatment. Conclusion: The causes of treatment failure in tularemia include delay in effective treatment and the development of suppurating lymph nodes.
Keywords
Tularemia; Treatment failure; Surgical procedures;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Perez-Castrillon JL, Bachiller-Luque P, Martin-Luquero M, Mena-Martin FJ, Herreros V. Tularemia epidemic in northwestern Spain: clinical description and therapeutic response. Clin Infect Dis 2001; 33:573-6.   DOI
2 Tezer H, Ozkaya-Parlakay A, Aykan H, Erkocoglu M, Gulhan B, Demir A, et al. Tularemia in children, Turkey, September 2009-November 2012. Emerg Infect Dis 2015;21:1-7.
3 Kosker M, Sener D, Kilic O, Akil F, Yilmaz M, Ozturk O, et al. A case of oculoglandular tularemia resistant to medical treatment. Scand J Infect Dis 2013;45:725-7.   DOI
4 Park CH, Nakanishi A, Hatai H, Kojima D, Oyamada T, Sato H, et al. Pathological and microbiological studies of Japanese Hare (Lepus brachyurus angustidens) naturally infected with Francisella tularensis subsp. holarctica. J Vet Med Sci 2009;71:1629-35.   DOI
5 Kizil Y, Aydil U, Cebeci S, Guzeldir OT, Inal E, Bayazit Y. Characteristics and management of intractable neck involvement in tularemia: report of 19 patients. Eur Arch Otorhinolaryngol 2012;269:1285-90.   DOI
6 Oz F, Eksioglu A, Tanir G, Bayhan G, Metin O, Teke TA. Evaluation of clinical and sonographic features in 55 children with tularemia. Vector Borne Zoonotic Dis 2014;14:571-5.   DOI
7 Penn RL. Francisella tularensis (tularemia). In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's principles and practice of infectious diseases, 7th ed. Philadelphia (PA): Elsevier-Churchill Livingstone, 2010:2927-37.
8 Boisset S, Caspar Y, Sutera V, Maurin M. New therapeutic approaches for treatment of tularaemia: a review. Front Cell Infect Microbiol 2014;4:40.
9 Enderlin G, Morales L, Jacobs RF, Cross JT. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin Infect Dis 1994;19:42-7.   DOI
10 Kaya A, Uysal IO, Guven AS, Engin A, Gulturk A, Icagasioglu FD, et al. Treatment failure of gentamicin in pediatric patients with oropharyngeal tularemia. Med Sci Monit 2011;17:CR376-80.
11 Kreizinger Z, Makrai L, Helyes G, Magyar T, Erdelyi K, Gyuranecz M. Antimicrobial susceptibility of Francisella tularensis subsp. holarctica strains from Hungary, Central Europe. J Antimicrob Chemother 2013; 68:370-3.   DOI
12 Gozel MG, Engin A, Altuntas EE, Salk I, Kaya A, Celik C, et al. Evaluation of clinical and laboratory findings of pediatric and adult patients with oropharyngeal tularemia in Turkey: a combination of surgical drainage and antibiotic therapy increases treatment success. Jpn J Infect Dis 2014;67:295-9.   DOI
13 Lamps LW, Havens JM, Sjostedt A, Page DL, Scott MA. Histologic and molecular diagnosis of tularemia: a potential bioterrorism agent endemic to North America. Mod Pathol 2004;17:489-95.   DOI
14 Kilic S, Celebi B, Acar B, Atas M. In vitro susceptibility of isolates of Francisella tularensis from Turkey. Scand J Infect Dis 2013;45:337-41.   DOI
15 Ulu-Kilic A, Gulen G, Sezen F, Kilic S, Sencan I. Tularemia in central Anatolia. Infection 2013;41:391-9.   DOI
16 Ellis J, Oyston PC, Green M, Titball RW. Tularemia. Clin Microbiol Rev 2002;15:631-46.   DOI
17 Tarnvik A, Chu MC. New approaches to diagnosis and therapy of tularemia. Ann N Y Acad Sci 2007;1105:378-404.   DOI